MNV
Market News Video
MNV MNV 10 Bargains You Can Buy Cheaper Than Insiders Did
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

How The Parts Add Up: ESML Targets $30
Wednesday, February 20, 9:30 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

GenMark Diagnostics Stock Sees Short Interest Decline 13%
Thursday, February 28, 11:41 AM ET, by Market News Video Staff

The most recent short interest data has been released for the 02/15/2019 settlement date, which ...

Short Interest Makes 22% Move For GNMK
Wednesday, March 27, 11:38 AM ET, by Market News Video Staff

The most recent short interest data has been released for the 03/15/2019 settlement date, which ...

Commit To Buy GenMark Diagnostics At $5, Earn 7.9% Annualized Using Options
Wednesday, April 17, 11:49 AM ET, by Market News Video Staff

Investors considering a purchase of GenMark Diagnostics, Inc. (GNMK) shares, but tentative about paying the ...

Implied ESML Analyst Target Price: $30
Tuesday, April 23, 7:52 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Oversold Conditions For GenMark Diagnostics (GNMK)

By Market News Video Staff, Monday, December 23, 4:20 PM ET
Play Video: Learn About The RSI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $4.95 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 78.5. A bullish investor could look at GNMK's 27.9 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of GNMK shares:

GenMark Diagnostics, Inc. 1 Year Performance Chart

Looking at the chart above, GNMK's low point in its 52 week range is $3.66 per share, with $8.37 as the 52 week high point — that compares with a last trade of $5.02. Find out what 9 other oversold stocks you need to know about »


Can your brain be trained to become a chart-predicting wizard? Click here to find out


This Article's Word Cloud:   About   Buffett   Click   Diagnostics   Find   GNMK   GenMark   Index   Know   Legendary   Looking   Monday   Oversold   Relative   Should   Start   Stocks   Strength   Warren   about   above   advises   after   analysis   become   begin   below   brain   bullish   called   changing   chart   compares   comparison   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

Oversold Conditions For GenMark Diagnostics (GNMK) | Market News Video | Copyright © 2008 - 2020, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.